<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05070182</url>
  </required_header>
  <id_info>
    <org_study_id>3/24-02.05.2018</org_study_id>
    <nct_id>NCT05070182</nct_id>
  </id_info>
  <brief_title>Resting Energy Needs in Brain Dead Patients (reSting EneRgy nEeds iN brAin DEad Patients)</brief_title>
  <acronym>SERENADE</acronym>
  <official_title>Resting Energy Needs in Brain Dead Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aristotle University Of Thessaloniki</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Papageorgiou General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Aristotle University Of Thessaloniki</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will examine the resting energy need (REE) in patients suffering from brain damage.&#xD;
      For the measurement of REE will be used a metabolic computer (which with continuous recording&#xD;
      of breath-to-breath volume (Vt), respiratory rate (RR) of ventilation per minute volume (MV)&#xD;
      ), of inhaled and exhaled gases (O2 and CO2) has the ability to calculate the values of VO2,&#xD;
      VCO2 and with the help of equations the values of REE and RQ.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a retrospective observational study concerning patients suffering from brain damage.&#xD;
&#xD;
      All the patients suffering from brain damage are monitored in order to examine their resting&#xD;
      energy needs (REE). For the measurement of REE the metabolic computer (Medical Graphics,&#xD;
      Ultima CCM, Minneapolis, USA) is used.&#xD;
&#xD;
      The main purpose of this study is to reveal the (REE) changing in patients with brain death&#xD;
      semiology and examine if the REE changes could be related to the outcome of a patient with&#xD;
      intracranial pathology. Moreover the study will examine if the changes in REE measurement are&#xD;
      related to changes in flow velocities in the midbrain.&#xD;
&#xD;
      Any measurement shall be preceded by calibration of the metabolic computer pneumotachograph&#xD;
      with a 3-liter syringe with an acceptable error of less than 9 ml / lit. The metabolic unit&#xD;
      is calibrated for VO2 measurements with two calibration cylinders containing 21% and 12% O2&#xD;
      and for VCO2 measurements with calibration gases containing 5% and 0% CO2 respectively.&#xD;
&#xD;
      The measurement of flow velocities in the middle cerebral artery will be done with the&#xD;
      transcranial Doppler using a low frequency (2 MHz) ultrasound head After their final&#xD;
      diagnosis (brain death or not) the patients' characteristics will be compared according to&#xD;
      the categorization as &quot;brain dead&quot; or not.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2018</start_date>
  <completion_date type="Actual">December 30, 2020</completion_date>
  <primary_completion_date type="Actual">June 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>REE changes</measure>
    <time_frame>Day 0 (upon entry to ICU) up to 30 days</time_frame>
    <description>Changes in REE in patients with brain damage</description>
  </primary_outcome>
  <primary_outcome>
    <measure>MCA changes</measure>
    <time_frame>Day 0 (upon entry to ICU) up to 30 days</time_frame>
    <description>Changes in flow rates in Median Cerebral Artery (MCA) in patients with brain damage</description>
  </primary_outcome>
  <primary_outcome>
    <measure>REE and MCA correlation</measure>
    <time_frame>Day 0 (upon entry to ICU) up to 30 days</time_frame>
    <description>Correlate the REE changes with those in flow rates in MCA</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prognostic value of REE</measure>
    <time_frame>Day 0 (upon entry to ICU) up to 30 days</time_frame>
    <description>Compare the values of REE upon entry in the ICU in patients with final diagnosis as brain dead or not</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">66</enrollment>
  <condition>Brain Death</condition>
  <condition>Brain Injuries</condition>
  <condition>Brain Edema</condition>
  <condition>Brain Hemorrhage</condition>
  <arm_group>
    <arm_group_label>Patients with brain damage</arm_group_label>
    <description>ICU patients with brain damage (due to cardiac arrest, intracranial hemorrhage or traumatic brain injury). and GCS upon entry &lt;=8.&#xD;
All patients will be examined with a transcranial doppler (TCD) and a metabolic computer (for the measurements of REE) After the final diagnosis the patients' characteristics will be compared according to if they were brain dead or not</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>REE - Resting Energy Expenditure</intervention_name>
    <description>REEs represent 60-70% of the needs for a sedentary person and 50% of physically active people.&#xD;
For the measurement of REE will be used the metabolic computer (Medical Graphics, Ultima CCM, Minneapolis, USA), which with continuous recording of breath-to-breath volume (Vt), respiratory rate (RR) of ventilation per minute volume (MV) ), of inhaled and exhaled gases (O2 and CO2) has the ability to calculate the values of VO2, VCO2 and with the help of equations the values of REE and RQ.&#xD;
All patients in the study will be monitored with the metabolic computer. Their measurements will be recorded every day during their stay in the ICU.</description>
    <arm_group_label>Patients with brain damage</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Transcranial Doppler</intervention_name>
    <description>The measurement of flow velocities in the middle cerebral artery will be done with the transcranial Doppler using a low frequency (2 MHz) ultrasound head.&#xD;
All patients entering the study will be examined with the TCD every day during their stay in the ICU.</description>
    <arm_group_label>Patients with brain damage</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients, aged 18-90 years old, entering the ICU, having a GCS &lt;=8 before any&#xD;
        intervention, having signs of intracranial damage after a traumatic brain injury or a&#xD;
        cardiac arrest succesfull rescucitation or a brain hemorrhage due to aneurysm.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patients entering the ICU&#xD;
&#xD;
          -  Age 18-90 years old&#xD;
&#xD;
          -  Clinical Diagnosis of brain damage&#xD;
&#xD;
          -  GCS &lt;=8&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients &lt;18 years old and &gt;90 years old,&#xD;
&#xD;
          -  Past history CNS disease (alzheimer's disease, multiple sclerosis, brain tumor,&#xD;
             aneurysm) in the last 3 years&#xD;
&#xD;
          -  Past history of cachexia due to cancer&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chryssa Pourzitaki, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculty of Medicine, School of Health Sciences, Aristotle University of Thessaloniki</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Papageorgiou General Hospital</name>
      <address>
        <city>Thessaloniki</city>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <reference>
    <citation>Babikian VL, Feldmann E, Wechsler LR, Newell DW, Gomez CR, Bogdahn U, Caplan LR, Spencer MP, Tegeler C, Ringelstein EB, Alexandrov AV. Transcranial Doppler ultrasonography: year 2000 update. J Neuroimaging. 2000 Apr;10(2):101-15. Review.</citation>
    <PMID>10800264</PMID>
  </reference>
  <reference>
    <citation>Marinoni M, Alari F, Mastronardi V, Peris A, Innocenti P. The relevance of early TCD monitoring in the intensive care units for the confirming of brain death diagnosis. Neurol Sci. 2011 Feb;32(1):73-7. doi: 10.1007/s10072-010-0407-1. Epub 2010 Sep 25.</citation>
    <PMID>20872036</PMID>
  </reference>
  <reference>
    <citation>Zijlstra N, ten Dam SM, Hulshof PJ, Ram C, Hiemstra G, de Roos NM. 24-hour indirect calorimetry in mechanically ventilated critically ill patients. Nutr Clin Pract. 2007 Apr;22(2):250-5.</citation>
    <PMID>17374800</PMID>
  </reference>
  <reference>
    <citation>Bitzani M, Matamis D, Nalbandi V, Vakalos A, Karasakalides A, Riggos D. Resting energy expenditure in brain death. Intensive Care Med. 1999 Sep;25(9):970-6.</citation>
    <PMID>10501754</PMID>
  </reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 17, 2021</study_first_submitted>
  <study_first_submitted_qc>September 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 7, 2021</study_first_posted>
  <last_update_submitted>September 26, 2021</last_update_submitted>
  <last_update_submitted_qc>September 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aristotle University Of Thessaloniki</investigator_affiliation>
    <investigator_full_name>Chrysoula Pourzitaki</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Resting energy expenditure (REE)</keyword>
  <keyword>Brain Death</keyword>
  <keyword>Brain injuries</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Brain Death</mesh_term>
    <mesh_term>Brain Edema</mesh_term>
    <mesh_term>Intracranial Hemorrhages</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

